Effect of α-tocopherol on antitubercular drugs induced hepatotoxicity


  • Rajiv Nehra Department of Biochemistry, LLRM Medical College, Meerut (U.P.),
  • Pinki Vishwakarma Department of Pharmacology, LLRM Medical College, Meerut (U.P.),
  • Manju Nehra Dental Surgeon, C.H.C. Siyana, Bulandshahr, (U.P.)
  • Shashank Tyagi Department of Biochemistry, LLRM Medical College, Meerut (U.P.),




Antitubercular drugs, Hepatotoxicity, α-tocopherol, Antioxidents


Background: Mycobacterium, the causative organism of tuberculosis, is notorious for its ability to develop resistance with monotherapy. To prevent emergence of resistance, combination of antitubercular drugs is given for months to years that can lead to side effects. Hepatotoxicity is one of the commonest side-effect with antitubercular drugs. This study was aimed to explore the hepatoprotective potential of α-tocopherol against experimentally induced hepatotoxicity in albino rabbits.

Methods: This experimental study was carried out on 30 rabbits of either sex.  They were divided into three groups comprising 10 animals each. Hepatotoxicity is induced experimentally in rabbits following a standard protocol. Group I received normal saline (10 ml/kg bw). Rabbits in group II were treated with first line antitubercular drugs isoniazid (5 mg/kg bw), rifampicin (20 mg/kg bw) and pyrazinamide (25 mg/kg bw) concurrently. Group III received α-tocopherol 200 mg/kg bw along with group II drugs. All drugs were administered by oral route for 90 days. On last day of experiment blood samples were taken to investigate the plasma levels of alanine aminotransferase (ALT), alkaline phosphatase (ALP) and serum total bilirubin.

Results: Serum levels of ALT were found to be markedly elevated upon oral administration of antitubercular drugs for 90 days. A statistically significant reduction in ALT levels was noticed when α-Tocopherol was given in doses of 200mg/kg bw along with antitubercular drugs for same duration. Similar results were obtained with serum ALP & serum total bilirubin.

Conclusions: α-tocopherol (200 mg/kg bw, oral) was found to have hepatoprotective effect against antitubercular drugs induced hepatotoxicity in albino rabbits.



Tripathi KD. Antitubercular drugs. In: KD Tripathi editor. Essentials of medical pharmacology.7th ed. New Delhi: Jaypee publication;2013. Pg 765.

Tripathi KD. Antitubercular drugs. In: KD Tripathi editor. Essentials of medical pharmacology. 7th ed.New Delhi: Jaypee publication;2013. Pg 773.

Garg PK, Tandon RK. Antitubercular drug induced hepatotoxicity. Sharma SK editor. Tuberculosis.1st ed. New Delhi: Jaypee publication, 2001. pg 500-506.

Chowdhury A, Santra A, Kundu S, Mukherjee A, Pandit A, Chaudhuri S. Induction of oxidative stress in antitubercular drug induced hepatotoxicity. Indian Journal Gastroenterol. 2001;20(3):97-100.

Tripathi KD. Antitubercular drugs. In: KD Tripathi editor. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee publication;2013. Pg 769.

Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D et al. A good practice guide to the administration of substances and removal of blood including routes and volumes, Journal of applied Toxicology. 2001;21;15-23.

Thomas BM, Woney T, Zeitz W. Isoniazid metabolism in rabbits and the effect of rifampicin pretreatment. Res Commmu in chem Path and Pharmacol .1981;33(2):235-7.

Sairch TC, Zhou T, Adams SP, Bain AI, Wall RA, Wright JM. A model of Isoniazid induced hepatotoxicity in rabbits. Journal of pharmacol toxicol methods. 1995;34(2):109-16.

Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003;362:887-99.

Girlig DJ. The hepatotoxicity of antituberculosis regimens containing Isoniazid, Rifampicin and Pyizinamide. Tubercle. 1978;59(1):13-32.

Durand F, Jebrak G, Pessayre D Fournier M, Bernuau J. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug safe.1996;15(6):394-405.

Shakya R, Rao SB, Shrestha B. Incidence of hepatotoxicity due to Antitubercular medicine and assessment of risk factors. Ann Pharmacother. 2004;38:1074-9.

Singhal KC, Grover JK, Moideen R, Kamini V. Incidence of adverse reactions to antitubercular drugs. Indian J Pharmacol.1990;5:1413-5.

Skakun NP, Slivka Iul. Effectiveness of tocopherol and anti hypoxic agents in liver damage caused by antitubercular agents. Probl Tuberk. 1991;(3):57-9.

Trush MA, Mimnaugh EG, Gram TE. Activation of pharmacologically active agents to radical intermediates .Implications for the role of free radicals in drug action and toxicity. Biochem pharmacol. 1982;31(21):3335-46.

Calva M, Campos-Apaez A, Rosales-Vega E, Mourelle M. Vitamin E improves membrane lipid alterations induced by CCl4 intoxication. J Appl Toxicol. 1984;4:270-2.

Karakilcik AZ, Hayat A, Zerin M, Cay M. Effects of intraperitonially injected selenium and vitamin E in rats anesthetized with halothane. J Trace Elem Med Biol. 2003;17(1):33-8.

Saraswathy SD, Suja V, Prema G, Shyamala DC. Effect of Liv.100 against antitubercular drugs (isoniazid, rifampicin and pyrazinamide) induced hepatotoxicity in rats. Indian J Pharmacol. 1998;30:233-8.




How to Cite

Nehra, R., Vishwakarma, P., Nehra, M., & Tyagi, S. (2016). Effect of α-tocopherol on antitubercular drugs induced hepatotoxicity. International Journal of Research in Medical Sciences, 4(4), 1158–1162. https://doi.org/10.18203/2320-6012.ijrms20160801



Original Research Articles